Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06275087Completed
Randomised, open-label trial of propofol injection (veterinary) and sevoflurane in Oral neoplasm (2 arms), sponsored by Clinical Hospital Center Zagreb. Primary endpoint: Quality of Recovery-40 at 30 days. Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06275087.